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Abstract
Background: The evaluation of malaria transmission intensity is a crucial indicator for estimating the burden of
malarial disease. In this respect, entomological and parasitological methods present limitations, especially in low
transmission areas. The present study used a sensitive multiplex assay to assess the exposure to Plasmodium
falciparum infection in children living in an area of low endemicity. In three Senegalese villages, specific antibody
(IgG) responses to 13 pre-erythrocytic P. falciparum peptides derived from Lsa1, Lsa3, Glurp, Salsa, Trap, Starp, Csp
and Pf11.1 proteins were simultaneously evaluated before (June), at the peak (September) and after (December)
the period of malaria transmission, in children aged from 1 to 8 years.
Results: Compared to other antigens, a high percentage of seropositivity and specific antibody levels were
detected with Glurp, Salsa1, Lsa3NR2, and Lsa1J antigens. The seropositivity increased with age for all tested
antigens. Specific IgG levels to Glurp, Salsa1, Lsa3NR2, and Lsa1J were significantly higher in P. falciparum infected
children compared to non-infected and this increase is significantly correlated with parasite density.
Conclusion: The multiplex assay represents a useful technology for a serological assessment of rapid variations in
malaria transmission intensity, especially in a context of low parasite rates. The use of such combined serological
markers (i.e. Glurp, Lsa1, Lsa3, and Salsa) could offer the opportunity to examine these variations over time, and to
evaluate the efficacy of integrated malaria control strategies.
Background
Plasmodium falciparum malaria is a major cause of
human morbidity and mortality in sub-Saharan Africa,
and its transmission varies greatly in endemicity across
the continent [1]. The expanding utilization of com-
bined malaria control strategies including insecticide
impregnated bednets and artemisinin combination
therapies, has contributed to greatly reduce malaria
transmission in several sub-Saharan African areas [2,3].
Consequently, the current methods for evaluating
malaria transmission intensity (MTI), such as entomolo-
gical inoculation rate and Plasmodium parasitemia in
human populations, present substantial limitations, e.g.
reproducibility and can be time-consuming. In addition,
both entomological and parasitological measures are
affected by the seasonality and require a precise follow-
up during longitudinal studies [4]. For this purpose,
there is an increased need for developing new tools for
the monitoring of MTI in more frequent contexts of
low malaria transmission. In this respect, the sero-epide-
miological approach offers a theoretical advantage over
parasite prevalence for assessing MTI or changes in pre-
valence following the implementation of control pro-
grammes [5]. In order to identify Plasmodium
infections, serological markers show greater sensitivity,
as seroprevalence reflects cumulative exposure to infec-
tions and thus is less affected by the changes in parasite
densities, which could be undetectable in the case of
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serological measurements are robust to detect short
term variations in transmission, and should be a perti-
nent tool for evaluating malaria exposure in the context
of low transmission [6].
The Circumsporozoite protein (CSP: a protein
expressed by sporozoites and early liver forms), has
been frequently used for the serological estimation of
MTI [7]. Controversial studies have reported that anti-
body (Ab) responses directed to the repetitive NANP
domains of CSP remained very low throughout the first
year of life [8]. In addition, it has been suggested that
human immunological memory following malaria infec-
tion is short-lived because Ab responses rapidly decline
after the end of the transmission season or exposure
period [9], and after treatment of a clinical episode [10].
It suggests that maintenance of immunological memory
therefore requires antigen persistence and may be age-
dependent [11]. For this purpose, it has been then
demonstrated that the simultaneous use of several anti-
gens (Ags) as serological markers could lead to a better
evaluation of malaria exposure than using only one Ag,
i.e. CSP [12]. Human Ab levels to plasmodial Ags are
classically assessed using the enzyme-linked immunosor-
bant assay (ELISA) test. This technique is labour-inten-
sive and time-consuming, as well as requiring
considerable quantity of Ags and sera samples. An
immunoassay that measures Ab to multiple Ags simulta-
neously would be highly advantageous [13]. Multiplexed
bead assays gives similar sensibility than ELISA assays,
and have been developed in several studies for simulta-
neous detection of Ab against multiple plasmodial Ags
in humans living in endemic areas [14,15].
In the present study, we used multiplex fluorescent
microsphere-based assays measuring simultaneously
human Ab to thirteen P. falciparum peptides [14] to
assess malaria transmission in children living in a low
endemicity area. All Ags used in the assay have pre-
viously been shown to be antigenic and associated with
malaria transmission in individuals living in malaria
endemic areas [6,14].
Materials and methods
Study population
The study was performed in the villages of Mboula
(Ferlo area: 15°40’ N, 15°25’ W), Gankette Balla (near
the Guiers Lake: 15°58’ N, 15°55’ W) and Mbilor (Low
valley area: 16°29’ N, 15°33’ W) in Northern Senegal,
located along the Senegal Basin River [16]. This site is a
dry savannah area, with approximately 400 mm of rain
by year. Malaria transmission is low (average of 3 to 7
infective bites per human per year), markedly seasonal
(occurring from July to October), with a peak in Sep-
tember [16].
Three cross-sectional surveys were performed in June,
September and December 2004 in the three villages. For
each passage, a sub-cohort of children aged from 1 to 8
years was randomly selected from an existing cohort of
450 children, as previously described [17]. A total of 186
children (Mboula n = 64; Gankette n = 56 and Mbilor n
= 66, selected for the 3 passages) were included in the
present study. For each child, parasitological measure-
ments of malaria were performed at each passage using
thick blood smears obtained by finger-prick. The smears
were Giemsa stained to identify Plasmodium species
and the number of malaria parasites was counted in 200
microscopic fields. Parasite density was defined as the
number of P. falciparum parasites/μlo fb l o o d ,c o r r e -
sponding to an average of 8000 leucocytes. In the same
way, capillary blood was collected from each child at
each passage for immunological assessments.
The present study followed ethical principles accord-
ing to the Helsinki Declaration, and was approved by
the Ethics Committee of the Ministry of Health of Sene-
gal (CNRS, June 2004). Informed consent was obtained
from the parents/tutors of the children.
Multiplex bead-based assay
The multiplex technique was performed using the same
sequences of P. falciparum peptides (Lsa1-41, Lsa1J,
Lsa3NR2, Lsa3RE, Glurp, Glurp.P3, Salsa1, Salsa2,
Trap1, Trap2, StarpR, Csp, Sr11.1), and the procedure
for coupling Ags to beads, as previously described [14].
Briefly, the P. falciparum peptides were synthesized with
an added N-terminal cysteine residue and covalently
coupled with bovine serum albumin by Genepep (Ales,
France). These Ags were coupled to beads (Biorad Inc,
CA, USA) and 50 μl/well was deposited at the final con-
centration of 80 beads/μl per peptide. Diluted individual
sera (1/100) in equal volumes of PBS and MFIA (Multi-
plex Fluorescence ImmunoAssay) diluents (Charles
River Laboratories Inc, MA, USA) were added in dupli-
cate using 50 μl/well. The Luminex system was set for
reading a minimum of 100 beads per spectral address,
and results were expressed as ΔMFI “median fluorescent
intensity” value with ΔMFI = MFIAg -M F I BSA,w h e r e
MFIAg represents the mean of individual MFI value for
beads coupled with P. falciparum Ag, and MFIBSA the
individual MFI value for each serum for beads without
coupled Ag. For calculating the seropositivity threshold,
the means and standard deviations (SD) of ΔMFI of
individuals living permanently in a non-endemic area (i.
e. negative control group - n = 19) were estimated for
each Ag. The lower limit of positivity of Ab responses
to one Ag was estimated as the mean of ΔMFI of the
negative control group + 3.09 SD. Therefore, values
higher than the cut-offs should be observed in less than
1% of sera of non-exposed individuals under the
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olds of positivity were 7466.6, 684.0, 725.0, 225.0, 344.2,
4593.1, 424.8, 439.7, 435.2, 933.6, 452.6, 380.2, and
302.5 respectively for Lsa1-41, Lsa1J, Lsa3NR2, Lsa3RE,
G l u r p ,G l u r p . P 3 ,S a l s a 1 ,S a l s a 2 ,T r a p 1 ,T r a p 2 ,S t a r p R ,
Csp, and SR11.1. Individual time-period variations in Ab
levels for each Ag were assessed by the ratio of ΔMFI
values collected at different time intervals, i.e. between
June - September; September - December or June - Sep-
tember. The significant increase in Ab level to each Ag
was defined as a value superior to the mean + 3.09 SD
of the ratio in ΔMFI in the negative control group col-
lected two times at four months interval.
Statistical analysis
All data were analyzed with Graph Pad Prism
® (Graph
Pad, San Diego, USA) version 4. After checking for nor-
mal distribution, the proportions of Ab-positive indivi-
duals and Ab levels were analyzed using the chi-squared
test, Mann-Whitney U-test, Kruskal-Wallis test, where
appropriate. Spearman’s correlation was used to check
for correlations between continuous variables. Differ-
ences were considered significant at P < 0.05.
Results and discussion
The proportion of seropositive and the level of specific
Ab (IgG) responses directed to different P. falciparum
peptides are presented for all studied individuals (Figure
1). A high IgG level was found in the majority of pep-
tides tested. Lsa1-41 presented the highest Ab
responses, i.e. antigenicity, with a ΔMFI mean of 7673
(95% CI = 7010 - 8336). Some other pre-erythrocytic
(GlurpP3, Salsa1, Glurp, Lsa3NR2, Trap2 and Lsa1J)
peptides were associated with moderate Ab response
levels with a ΔMFI values ranging from 665 (95% CI =
473.9 - 857.1) to 3000 (95% CI = 2890 - 3265). In con-
t r a s t ,S t a r p R ,C s p ,T r a p 1 ,S a l s a 2 ,S r 1 1 . 1a n dL s a 3 R E
peptides presented lower levels of antigenicity. The pro-
portion of seropositive was markedly higher for the
Glurp peptide. Moderate seroprevalence was observed
for Salsa1, Lsa1-41, Starp, Lsa3NR2, and Lsa1J peptides,
whereas a very low proportion of seropositive was
observed for all other Ags. These results suggested that
pre-erythrocytic Lsa1-41, Salsa1, Glurp, Lsa1J and
Lsa3NR2 peptides appeared to be most antigenic, giving
the highest proportion of seropositive, and therefore
could be potential serological markers of malaria trans-
m i s s i o n .H o w e v e r ,i tc a nn o tb ee x c l u d e dt h a td i f f e r -
ences in antigenicity levels (ΔMFI values) between these
peptides could be due also to the different structure of
repetitive epitopes and to their conformation when they
are coupled to the beads, as previously indicated [18].
Furthermore, the specific Ab response levels and the
seropositivity (Table 1) to these relevant antigens (Lsa1-
41, Salsa1, Glurp, Lsa1J and Lsa3NR2) were investigated
according to the village and period of malaria transmis-
sion. No statistical influence of village and of time-per-
iod on specific Ab level (data not shown) and
seropositivy were observed. These results could be
attributed to the similar prevalence of P. falciparum in
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Figure 1 Proportion of seropositive and Ab levels to P. falciparum peptides (n = 186). Black and gray bars indicate respectively the Ab
levels (ΔMFI) and proportion of seropositive. Error bars indicate the upper limits of the 95% confidence intervals.
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Page 3 of 8children in June (37.3%, n = 22), September (40.3%, n =
25) and December (43.1%, n = 28) and according to the
village (Mboula 45.3%, n = 29; Gankette 41.1%, n = 23;
Mbilor 34.9%, n = 23).
In the objective to explore the possibility that these
potential serological markers could reflect exposure to
malaria over a prolonged period, the proportion of ser-
o p o s i t i v et oa tl e a s to n ep e p t i d e ,a n dt h en u m b e ro f
peptides that showed seropositivity in children were
analyzed according to age (Figure 2). The seropositivity
to at least one peptide increased significantly according
to age group, and remained higher in older (> 5 years)
than in younger (≤5 years) children (P < 0.001). The
number of peptides for which children developed high
IgG titers was significantly age-dependant (P < 0.001).
L s a 1 - 4 1 ,S a l s a 1 ,G l u r p ,L s a 3 N R 2 ,T r a p 2 ,C s p ,T r a p 1 ,
Salsa2 and StarpR peptides showed a significant
increase of seropositivity with age (all P < 0.02). In
addition, in older children (7-8 years) who were sero-
positive to at least one peptide, 93.0% (40 of 43) were
seropositive to at least one of 4 specific peptides: Lsa1-
41, Salsa1, Glurp and Lsa3NR2. These results sug-
gested that seropositivy to peptide reflects cumulative
exposure to malaria infection, and that it could need
Table 1 Proportion and number of seropositive according to the period of malaria transmission and village.
Mboula (n = 64) Gankette (n = 56) Mbilor (n = 66) All villages (n = 186)
June Sept Dec June Sept Dec June Sept Dec June Sept Dec
Lsa1-41 6.7%
(1/15)
18.2%
(4/22)
25.9%
(7/27)
22.2%
(4/18)
26.3%
(5/19)
36.8%
(7/19)
7.7%
(2/26)
14.3%
(3/21)
15.8%
(3/19)
11.9%
(7/59)
19.3%
(12/62)
26.1%
(17/65)
Salsa1 26.7%
(4/15)
9.1%
(2/22)
22.2%
(6/27)
22.2%
(4/18)
15.8%
(3/19)
15.8%
(3/19)
23.1%
(6/26)
23.8%
(5/21)
15.8%
(3/19)
23.7%
(14/59)
16.1%
(10/62)
18.5%
(12/65)
Glurp 46.7%
(7/15)
31.8%
(7/22)
48.1%
(13/27)
44.4%
(8/18)
42.1%
(8/19)
31.6%
(6/19)
61.5%
(16/26)
47.6%
(10/21)
68.4%
(13/19)
52.5%
(31/59)
40.3%
(25/62)
49.2%
(32/65)
Lsa1J 33.3%
(5/15)
31.8%
(7/22)
29.6%
(8/27)
16.7%
(3/18)
15.8%
(3/19)
21.0%
(4/19)
7.7%
(2/26)
4.8%
(1/21)
5.3%
(1/19)
16.9%
(10/59)
17.7%
(11/62)
20.0%
(13/65)
Lsa3NR2 6.7%
(1/15)
9.1%
(2/22)
25.9%
(7/27)
27.8%
(5/18)
31.6%
(6/19)
36.8%
(7/19)
11.5%
(3/26)
38.1%
(8/21)
10.5%
(2/19)
15.2%
(9/59)
25.8%
(16/62)
24.6%
(16/65)
The prevalence rate of positive P. falciparum infection was 37.3%, 40.3%, 43.1% respectively at June, September, December and 45.3%, 41.1% and 34.9%
respectively in Mboula, Gankette and Mbilor villages.
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Figure 2 Number of P. falciparum peptides that produced seropositive results and proportion of seropositive to at least one peptide,
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Page 4 of 8more than one peptide for assessing MTI. The need to
use several peptides for pertinent MTI evaluation
appeared relevant especially in young children (< 5
years), as previously described [19].
The incidence rate of a significant increase in IgG
level to P. falciparum peptides is shown according to
the 3 time-periods, i.e. between June - September (Fig-
ure 3A); September - December (Figure 3B) and June -
December 2004 (Figure 3C). Significant increase of spe-
cific IgG levels to at least one peptide was observed for
33.3% (95% CI = 17.2-49.5%), 45.7% (95% CI = 28.3-
63.1%) and 51.3% (95% CI = 34.4-68.2%) of individuals,
between June-September; September-December and
June-December, respectively. In particular, IgG levels to
Glurp, Lsa1J, Salsa1, Csp, and Lsa3NR2 increased signif-
icantly whatever the time-period studied. In contrast, no
increase in Ab was observed for Lsa3RE, Salsa2, Sr11.1,
Glurp.P3 and Trap1 (data not shown). Among the 47
individuals presenting a significant increase of Ab to at
least one peptide between the different periods, 25
(53.2%), 16 (34.0%), 15 (31.9%), 6 (12.8%), 6 (12.8%), 5
(10.6%) showed an increased IgG to Glurp, Lsa1J,
June - September
September - December 
June – December 
Glurp Salsa1 Lsa1J Starp Csp   Lsa3NR2 Trap2
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Figure 3 Incidence of significant increases in specific Ab to P. falciparum peptides (Glurp, Salsa1, Lsa1J, Starp, Csp, Lsa3NR2, Lsa1, and
Trap2) between June - September (Figure 3A, n = 33); September - December (Figure 3B, n = 32) and June - December 2004 (Figure
3C, n = 33). For all other peptides, no significant increase in Ab was observed during the period of malaria transmission. Error bars indicate the
upper limits of the 95% confidence intervals.
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Page 5 of 8Salsa1, Starp, Lsa3NR2 and Csp respectively. Moreover,
the incidence rate of increased IgG levels to Glurp,
Salsa1 and Lsa1J, were significantly higher compared to
others peptides (all P < 0.02), and then, whatever the
periods of malaria transmission considered. Altogether,
these results suggested that Glurp, Salsa1, Lsa1J,
Lsa3NR2 and Csp peptides could be the relevant candi-
dates for evaluating potential season-dependent varia-
tions of malaria exposure. In addition, the increase of
the number of Ags tested may provide a better estima-
tion of malaria transmission, particularly in areas of low
endemicity.
Specific Ab levels to P. falciparum peptides were com-
pared according to the presence of malaria infection in
children (Figure 4). Positive children for P. falciparum
(n = 75), presented higher specific Ab response to
Glurp, Salsa1, Lsa3NR2, and Lsa1J peptides (all P <
0.05) than negative children (n = 111). In P. falciparum
infected children, 80.0%, 54.7%, 62.7%, and 50.7% were
seropositive to Glurp, Lsa3NR2, Salsa1 and Lsa1J
respectively. Moreover, 85.3% of P. falciparum infected
children were seropositive for at least one of the candi-
date antigens (Glurp, Lsa3NR2, Salsa1, and Lsa1J). For
other peptides, no significant differences of Ab response
levels were observed between P. falciparum positive and
negative children (data not shown). Moreover, the high-
est differences in specific IgG levels were respectively
observed for Glurp, Salsa1, Lsa3NR2 and Lsa1J. The sta-
tistical correlation between specific IgG level and the P.
falciparum parasite density indicated a positive and sig-
nificant correlation for Glurp, Salsa1, Lsa3NR2, and
Lsa1J (all r >0 . 3 2 0 ,a l lP < 0.01). Altogether, these data
suggested that Glurp, Salsa1, Lsa3NR2 and Lsa1J pep-
tides seem to be closely associated with P. falciparum
parasite presence and intensity, and could be therefore
potential serological markers of malaria exposure. This
positive association between P. falciparum infection and
specific Ab response against plasmodial antigens is a
consistent observation, and could result from a booster
effect of sustained parasite-exposure [6,20-22].
Some of these antigens (Glurp, Lsa1J, Lsa3NR2, and
Salsa1) appeared to satisfy several of the requirements
expected for a relevant marker of MTI. These peptides
are antigenic and provided a higher incidence rate of
significant increases in IgG levels. Specific Ab levels to
these Ags are closely associated with the presence and
the intensity of malaria infection. Moreover, in children
seropositive to at least one peptide, 86.3% (120 of 139)
were seropositive to at least one out of these four pep-
tides. Pre-erythrocytic Glurp, Lsa1, Lsa3 and Salsa Ags
are mainly expressed in infected human hepatocytes,
they present little polymorphism from geographically
different P. falciparum isolates [23-26]. Recent immuno-
epidemiological studies in different endemic areas, have
shown a positive association of specific Ab directed to
these Ags and the level of malaria transmission [14].
Our results strengthen that pre-erythrocyte Ags, and
particularly Glurp, Lsa1, Lsa3, and Salsa, could be
0
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Figure 4 Differences in specific Ab response directed to Glurp, Salsa1, Lsa3NR2 and Lsa1J peptides according to the presence (n = 75)
or absence (n = 111) of P. falciparum infection. Pf + and Pf - = P. falciparum positive and negative children. P value of the Mann-Whitney U-
test.
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Page 6 of 8pertinent markers to assess and to survey malaria trans-
mission, at the individual level and in the context of low
P. falciparum prevalence. Nevertheless, further studies
will be valuable for validating these potential serological
markers. These studies could include future modelling
exercises including covariates factors such as age,
genetic background, village of residence, impact of vec-
tor/parasite control programmes and the period of
transmission. This kind of tool could allow elaborating a
precise picture of malaria epidemiology in large-scale
areas, or be used as a complementary indicator for eval-
uating the efficacy of integrated malaria control
strategies.
Conclusion
In conclusion, the multiplex assay provides a useful tool
to simultaneously measured Ab responses directed to
several Ags used as potential markers of malaria trans-
mission. In low transmission areas, serological measure-
ments to various malaria antigens are needed for
estimating short term and small scale variations in MTI.
However, the present study suggests that the combined
assessment of Ab levels to only Glurp, Lsa1, Lsa3, and
Salsa Ags could be a pertinent serological marker for
evaluating the MTI.
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